Ayurveda Alongside Targeted Therapy: — An Honest Assessment

Haldi as a cooking spice is not a concern — the amount of curcumin absorbed from food is small. High-dose curcumin capsules and concentrated extracts are a different matter. At supplemental doses, curcumin is documented to affect liver enzymes and may alter the absorption of some targeted therapy drugs. If someone has recommended curcumin capsules to you, tell your oncologist about that specifically, because it is not the same as cooking with haldi.

Ashwagandha is widely used in India and has genuine evidence for reducing stress and fatigue. It also has immunomodulatory effects — meaning it influences immune activity — and is processed by some of the same liver enzymes as several targeted therapy drugs. The published data on interactions specifically with cancer drugs is still developing. This is one to discuss with your oncologist rather than discontinue automatically or continue without disclosing.

Giloy became widely used after COVID and many families continue it as a general health measure. There are published case reports of liver injury associated with giloy preparations, some in people who had no prior liver problems. During targeted therapy, when the liver is already under monitoring and some additional strain, this is a preparation worth mentioning to your oncologist specifically — not because it will certainly cause harm, but because the risk is not zero and the evidence base is still being built.

Triphala is a combination of three fruits used widely as a digestive aid. Because oral targeted therapy drugs are absorbed through the gut, anything that affects gut transit or the gut lining has the potential to affect how much drug enters the bloodstream. The evidence on triphala and cancer drug interactions is limited, which means genuine uncertainty rather than demonstrated safety. Tell your team you are taking it so they can factor it into your monitoring.

Kadha is prepared at home or by practitioners and the composition varies enormously — which is exactly what makes it difficult to assess from the outside. A preparation containing one mild herb is very different from one with concentrated extracts of several plants. The practical step is to bring the ingredient list, or your practitioner's written prescription, to your oncology appointment. Your team can then assess what is in it rather than giving a blanket answer.

Neem is used in many forms — leaves, oil, and extracts — and is widely regarded as a general health supplement. It does have pharmacological activity; laboratory studies have suggested interactions with drug-metabolising enzymes, though evidence from people taking targeted therapy alongside neem is limited. The question to ask your team is not whether neem is harmful in general but whether the amount and form you are using is compatible with your specific treatment and dose.